Yes, you can start hormone therapy during perimenopause. You do not have to wait until your periods stop completely or until you are officially postmenopausal.
Hormone therapy may be appropriate when symptoms such as hot flashes, night sweats, sleep disruption, vaginal dryness, or cycle-related changes begin affecting your quality of life. The right time to start depends less on a specific hormone level and more on your symptoms, menstrual pattern, medical history, pregnancy risk, and treatment goals.
Current clinical guidelines recognize perimenopause as part of the menopause spectrum and support menopausal hormone therapy for appropriate candidates experiencing bothersome symptoms.
That does not mean every symptom in your 40s requires estrogen or progesterone. Fatigue, poor sleep, low mood, irregular periods, and weight changes can also be connected to thyroid disorders, anemia, pregnancy, sleep apnea, medication effects, metabolic dysfunction, stress, or other medical conditions.
The goal is not simply to “replace hormones.” It is to determine what is changing, rule out important alternatives, and choose the safest treatment for the individual in front of us.
What Is Perimenopause?
Perimenopause is the transition leading up to menopause. It often begins in the 40s, although symptoms may start earlier.
During this stage, ovarian hormone production becomes less predictable. Estrogen may rise sharply during one part of the month and fall during another. Progesterone production often becomes less consistent as ovulation occurs less regularly.
These fluctuations may lead to symptoms such as:
- Hot flashes
- Night sweats
- Difficulty sleeping
- Irregular or heavier periods
- Breast tenderness
- Mood changes
- Increased anxiety
- Brain fog
- Vaginal dryness
- Pain during sex
- Reduced libido
- Headaches or migraines
- Joint or muscle discomfort
- Changes in body composition
Perimenopause does not mean estrogen is consistently low. Hormone levels may fluctuate significantly from one day or menstrual cycle to the next. That variability helps explain why symptoms can feel severe one week and almost disappear the next.
Menopause itself is confirmed after 12 consecutive months without a menstrual period, assuming there is no other medical reason for the missed periods. Until then, pregnancy may still occur.
Do You Have to Wait Until Menopause to Start HRT?
No. Women experiencing bothersome symptoms can be evaluated for hormone therapy before their final menstrual period.
The European Society of Endocrinology recommends considering perimenopause when menstrual irregularity, hot flashes, night sweats, or related symptoms are present. Its 2025 guideline states that women in perimenopause who are appropriate candidates may be treated with menopausal hormone therapy.
The Menopause Society also confirms that hormone therapy can treat bothersome hot flashes and night sweats during perimenopause. Women who are still having menstrual cycles may experience breakthrough bleeding, so the type and schedule of treatment matter.
In other words, the calendar does not determine treatment by itself. Symptoms, risks, bleeding patterns, contraception needs, and personal preferences all matter.
Waiting until symptoms become unbearable is not a medical requirement. At the same time, starting treatment simply because you reached a certain age is not automatically appropriate.
What Symptoms Can Hormone Therapy Help?
Systemic menopausal hormone therapy is considered the most effective treatment for vasomotor symptoms, meaning hot flashes and night sweats. It may also help related sleep disruption when nighttime symptoms repeatedly wake you.
Hormone therapy may be considered for:
Hot flashes and night sweats
These are among the most common and well-supported reasons for using systemic hormone therapy. The Menopause Society identifies hormone therapy as a first-line treatment for bothersome vasomotor symptoms in appropriate candidates.
Sleep disruption
Hormone therapy may improve sleep when night sweats, temperature changes, or other menopause symptoms are causing awakenings.
However, not all midlife sleep problems are hormonal. Sleep apnea, restless legs syndrome, alcohol use, anxiety, medication effects, blood sugar instability, and poor sleep habits may also contribute.
Vaginal and urinary symptoms
Declining estrogen exposure may contribute to:
- Vaginal dryness
- Burning or irritation
- Pain during sex
- Urinary urgency
- Recurrent urinary discomfort
Low-dose vaginal estrogen may be used when symptoms are primarily vaginal or urinary. Because treatment is applied locally, it produces much lower systemic exposure than full-body hormone therapy.
Women who also have hot flashes, night sweats, or widespread symptoms may need systemic treatment, local treatment, or both, depending on their response.
Menstrual changes
Hormone therapy may help some women with perimenopausal symptoms, but unexpected, unusually heavy, or persistent bleeding should not automatically be blamed on hormones.
Bleeding changes may require evaluation for pregnancy, fibroids, polyps, endometrial changes, thyroid dysfunction, bleeding disorders, or other gynecologic conditions.
Bone protection
Systemic hormone therapy prevents bone loss and reduces fracture risk while it is being used. That benefit may be especially important for women with premature ovarian insufficiency or early menopause.
Hormone therapy should not, however, be prescribed as a universal anti-aging treatment or as the primary way to prevent heart disease or dementia. Current guidelines support using it for appropriate clinical indications, not as a promise of indefinite youth wrapped in a prescription label.
Do You Need Hormone Testing Before Starting?
Not always.
For women older than 45 who have typical perimenopausal symptoms and menstrual changes, routine blood testing is often not necessary to diagnose perimenopause. Hormone levels can change dramatically throughout the menstrual cycle, so a single follicle-stimulating hormone, estradiol, or progesterone result may not accurately represent the overall pattern.
Testing may be more useful when:
- Symptoms begin before age 45
- Periods stop or become irregular before age 40
- The diagnosis is uncertain
- Pregnancy is possible
- Symptoms suggest thyroid disease
- Bleeding is unusually heavy or persistent
- Fatigue may be related to anemia or nutrient deficiency
- There are signs of polycystic ovary syndrome
- A medication or medical condition may be affecting the menstrual cycle
- Symptoms do not respond as expected to treatment
A thorough evaluation may include pregnancy testing, thyroid markers, a complete blood count, iron status, metabolic markers, or other testing based on the symptoms and medical history.
This distinction matters: blood work does not always “prove” perimenopause, but targeted testing can help identify other factors that may look like perimenopause or make its symptoms worse.
What Types of Hormone Therapy Can Be Used During Perimenopause?
There is no single perimenopause prescription that works for everyone. Treatment depends on whether you still have a uterus, whether contraception is needed, your bleeding pattern, symptom severity, medical risks, and how you respond.
Estrogen therapy
Estrogen is the primary hormone used to treat hot flashes, night sweats, vaginal symptoms, and related menopause symptoms.
Systemic estrogen is available as:
- Skin patches
- Topical gels or sprays
- Oral tablets
Transdermal estrogen is absorbed through the skin. Oral estrogen passes through the liver before reaching the bloodstream.
That difference may matter for women with certain cardiovascular or metabolic risks. Oral estrogen can affect liver-produced clotting factors, triglycerides, and inflammatory markers more than transdermal estrogen. Guidelines commonly favor transdermal estrogen for women with elevated risk of venous thromboembolism, obesity, controlled hypertension, or diabetes.
The best route still depends on the individual. Convenience, cost, skin sensitivity, medical history, symptom response, and personal preference all play a role.
Progesterone or another progestogen
A woman who still has her uterus generally needs adequate progesterone or another progestogen when using systemic estrogen.
Estrogen stimulates the uterine lining. Using systemic estrogen without adequate endometrial protection can increase the risk of endometrial hyperplasia and endometrial cancer. Current guidelines recommend combined estrogen and progestogen therapy for women with a uterus.
Progesterone may be taken:
- Every day
- For part of each month
- Through certain hormone-releasing intrauterine devices
The schedule may affect bleeding. A cyclic approach may lead to predictable withdrawal bleeding, while a continuous approach is often intended to reduce bleeding over time. Perimenopausal hormone fluctuations can make bleeding less predictable during the first months of treatment.
Hormonal contraception
Some women in perimenopause may benefit more from a combined hormonal contraceptive than from traditional menopausal hormone therapy.
This may be considered when the main priorities include:
- Preventing pregnancy
- Controlling heavy or irregular periods
- Reducing menstrual symptoms
- Treating hot flashes or night sweats
- Suppressing unpredictable ovarian cycling
Combined hormonal contraceptives typically contain higher hormone doses than menopausal hormone therapy and have their own eligibility criteria and risk profile.
They may not be appropriate for women with certain migraine patterns, uncontrolled blood pressure, smoking history, clotting risk, cardiovascular disease, or other contraindications.
Hormonal intrauterine device plus estrogen
A levonorgestrel-releasing intrauterine device may provide contraception, reduce heavy bleeding, and protect the uterine lining. Estrogen can then be added separately to treat hot flashes, night sweats, and other systemic symptoms.
The Menopause Society identifies this as one possible option for women who need both endometrial protection and symptom treatment during perimenopause.
Vaginal estrogen
Low-dose vaginal estrogen may be appropriate when symptoms are limited mainly to vaginal dryness, discomfort during sex, or urinary symptoms.
It is available in several forms, including:
- Creams
- Tablets or inserts
- Vaginal rings
Low-dose vaginal treatment is different from systemic estrogen. It is intended to treat local tissue symptoms rather than whole-body symptoms such as hot flashes.
Hormone Therapy Is Not Birth Control
Menopausal hormone therapy does not reliably prevent pregnancy.
Even with irregular periods, ovulation may still occur during perimenopause. Women who do not want to become pregnant should continue using effective contraception until menopause has been confirmed or until a clinician determines contraception is no longer necessary.
This is one reason the treatment conversation should include reproductive goals rather than focusing only on symptom relief.
A woman may need:
- Menopausal hormone therapy plus nonhormonal contraception
- A hormone-releasing intrauterine device plus estrogen
- Combined hormonal contraception instead of menopausal hormone therapy
- A nonhormonal menopause treatment plus contraception
Trying to solve every midlife symptom with one medication is tempting, but physiology rarely rewards that level of optimism.
Who May Be a Good Candidate?
Hormone therapy may be considered for a woman who:
- Has bothersome hot flashes or night sweats
- Has sleep disruption linked to menopause symptoms
- Has vaginal or urinary symptoms
- Is experiencing early menopause or premature ovarian insufficiency
- Has symptoms that interfere with work, relationships, exercise, or daily life
- Understands the potential benefits and risks
- Does not have a clear contraindication
- Is willing to attend follow-up appointments and report bleeding or adverse effects
For most healthy women who are younger than 60 or within 10 years of menopause onset, the benefit-risk profile is generally considered favorable when hormone therapy is used for appropriate symptoms and individualized to the patient.
Age alone is not enough to determine eligibility. Neither is one “normal” hormone result.
Who Needs Additional Evaluation?
Systemic hormone therapy may not be appropriate, or may require specialist review, for women with a history of:
- Breast cancer or another hormone-sensitive cancer
- Blood clots or pulmonary embolism
- Stroke, heart attack, or significant cardiovascular disease
- Unexplained vaginal bleeding
- Active liver disease
- A known clotting disorder
- Untreated or uncontrolled high blood pressure
- Pregnancy or suspected pregnancy
A prior condition does not always produce a simple yes-or-no answer. The type of condition, time since the event, current medications, hormone route, symptom severity, and available alternatives all matter.
For example, current European guidance recommends that women with a previous blood clot who are being considered for hormone therapy receive an individualized risk assessment. When treatment is appropriate, low-dose transdermal estrogen may be favored over oral estrogen.
Systemic menopausal hormone therapy is generally not recommended for women with a history of breast cancer. Low-dose vaginal estrogen may sometimes be considered for persistent genitourinary symptoms when nonhormonal options have failed, but that decision should involve the woman’s oncology and menopause care teams.
What Are the Risks of Starting Hormone Therapy?
The risks are not identical for every woman or every hormone product.
They may vary based on:
- Age
- Time since menopause
- Estrogen route
- Estrogen dose
- Type of progestogen
- Length of treatment
- Personal breast cancer risk
- Cardiovascular health
- Smoking status
- Blood pressure
- Body composition
- History of blood clots
- Whether the uterus is present
Potential risks may include blood clots, stroke, gallbladder disease, breast cancer, or endometrial cancer when systemic estrogen is used without adequate uterine protection.
These risks should be discussed in context rather than presented as though every formulation carries the same probability.
In February 2026, the U.S. Food and Drug Administration approved labeling changes for six menopausal hormone therapy products, removing cardiovascular disease, breast cancer, and probable dementia statements from the boxed warning. The agency did not erase these risks from all safety information, nor did it remove the endometrial cancer warning for systemic estrogen used without adequate protection in women with a uterus.
The change reinforces an important point: treatment decisions should reflect current evidence, formulation, timing, and personal risk rather than relying on fear generated from older studies involving different populations and treatment patterns.
What About “Bioidentical” Hormone Therapy?
The term “bioidentical” means the hormone has the same chemical structure as a hormone produced by the human body.
Several regulated prescription products contain bioidentical hormones, including estradiol and micronized progesterone.
Bioidentical does not automatically mean compounded. It also does not automatically mean safer.
Compounded hormone products may be useful in limited circumstances, such as a documented allergy to an ingredient in an approved product or a need for a formulation that is not commercially available. However, compounded products do not undergo the same testing for potency, consistency, safety, and effectiveness as approved medications.
The American College of Obstetricians and Gynecologists advises that approved menopausal hormone therapies should generally be used instead of routinely prescribing compounded bioidentical hormone therapy when an approved option is available.
Customized care should mean choosing the right evidence-based formulation, dose, route, and follow-up plan. It should not mean assuming that an unregulated product is superior because its marketing sounds more natural.
What Should Be Checked Before Starting?
A hormone therapy evaluation may include:
Symptom history
Your clinician should ask when symptoms began, how often they occur, what makes them worse, and how much they affect your life.
Menstrual and bleeding history
Important details include:
- Cycle frequency
- Missed periods
- Heavy bleeding
- Bleeding between periods
- Bleeding after sex
- Recent changes in bleeding duration
- Date of the last menstrual period
Pregnancy and contraception needs
Hormone therapy does not prevent pregnancy, so reproductive plans need to be addressed.
Medical and family history
This should include breast cancer, ovarian cancer, uterine cancer, blood clots, stroke, cardiovascular disease, migraines, liver disease, diabetes, blood pressure, and bone health.
Medication and supplement review
Certain medications may affect bleeding, hormone metabolism, clotting risk, sleep, mood, or sexual function.
Appropriate screening
Routine preventive care should be current based on age and individual risk. This may include breast screening, cervical cancer screening, blood pressure evaluation, and metabolic health assessment.
Hormone therapy should not be treated as a “set it and forget it” subscription. Symptoms, bleeding, side effects, and health risks can change.
What Happens After You Start?
The initial dose is often selected based on symptoms, age, medical history, uterine status, and treatment route.
During the first few weeks, some women may experience:
- Breast tenderness
- Bloating
- Headaches
- Mood changes
- Spotting or breakthrough bleeding
- Skin irritation from a patch
- Drowsiness after oral progesterone
Not every side effect means treatment must stop. Sometimes changing the dose, route, product, or progesterone schedule improves tolerability.
The 2025 European Society of Endocrinology guideline recommends reassessing treatment effects after approximately three months. If symptoms remain uncontrolled or adverse effects occur, the formulation and dose should be reviewed.
Follow-up should assess:
- Symptom improvement
- Sleep quality
- Bleeding pattern
- Blood pressure
- Side effects
- Medication adherence
- New medical diagnoses
- Changes in breast or cardiovascular risk
- Whether the treatment still fits the patient’s goals
Seek prompt medical evaluation for chest pain, shortness of breath, one-sided leg swelling, sudden neurological symptoms, severe new headaches, or unusually heavy bleeding.
Can Hormone Therapy Help With Perimenopause Weight Gain?
Hormone therapy is not a weight-loss medication.
It may indirectly support body-composition efforts when it improves sleep, night sweats, fatigue, or other symptoms that interfere with exercise, nutrition, and recovery. It may also influence how fat is distributed during the menopause transition.
However, unexplained or persistent weight gain may involve more than reproductive hormones.
A broader evaluation may include:
- Protein and calorie intake
- Resistance training
- Daily movement
- Sleep duration and quality
- Thyroid function
- Insulin resistance
- Medication effects
- Alcohol intake
- Stress
- Loss of muscle mass
- Menopause-related changes in fat distribution
Hormone therapy may be one part of a plan, but it should not be marketed as a shortcut for fat loss.
Can You Start Progesterone Without Estrogen?
In some situations, a clinician may prescribe progesterone or a progestogen without adding estrogen immediately.
This may be considered when irregular ovulation, heavy bleeding, cycle changes, or sleep symptoms are prominent. The decision depends on the person’s symptoms, bleeding pattern, contraceptive needs, and medical history.
Evidence for progesterone-only treatment is not as broad as the evidence supporting estrogen for hot flashes and night sweats. A woman with significant vasomotor symptoms may ultimately need estrogen or a nonhormonal vasomotor treatment.
Progesterone should not be treated as a universal first step simply because it commonly declines during perimenopause. Treatment should match the symptom pattern and clinical goal.
Frequently Asked Questions:
Can I take hormone therapy if I still have regular periods?
Possibly. Regular periods do not rule out perimenopause, particularly when hot flashes, night sweats, sleep disruption, or other typical symptoms are present. Your contraception needs and bleeding pattern will affect which treatment is most appropriate.
Is 40 too young to start hormone therapy?
Not necessarily. Current guidelines recommend considering perimenopause in women ages 40 to 45 who develop menstrual irregularity or vasomotor symptoms. Testing may be considered when symptoms occur at this age because other diagnoses and early menopause may need evaluation.
What if symptoms begin before age 40?
Symptoms before age 40 require a more detailed evaluation for premature ovarian insufficiency and other causes. Hormone testing is generally recommended when menstrual irregularity, infertility, or vasomotor symptoms suggest premature ovarian insufficiency.
Will hormone therapy stop my periods?
Not always. Bleeding may continue during perimenopause, and the treatment schedule may cause predictable or unpredictable bleeding. Any persistent, heavy, or concerning bleeding should be evaluated.
How long can I stay on hormone therapy?
There is no universal expiration date. Treatment duration should depend on symptom control, health risks, bone health, quality of life, and personal preference. Ongoing therapy should be reassessed periodically rather than stopped automatically at a specific birthday.
Can I use testosterone during perimenopause?
Testosterone is not a standard treatment for general perimenopause symptoms, fatigue, weight gain, or brain fog. Evidence-based use is generally focused on carefully diagnosed hypoactive sexual desire disorder in selected postmenopausal women. There is no U.S. Food and Drug Administration-approved testosterone product specifically formulated for women, so dosing and monitoring require particular care.
The Bottom Line
You can start hormone therapy during perimenopause. You do not have to wait until your periods stop or your symptoms reach some imaginary threshold of misery.
The best treatment depends on:
- Which symptoms are affecting you
- Whether pregnancy prevention is needed
- Whether you still have a uterus
- Your bleeding pattern
- Your medical and family history
- Your cardiovascular and breast health
- The route and dose of treatment
- Your personal goals and preferences
Hormone therapy can be highly effective, but it should be part of a thoughtful evaluation rather than a reflex prescription.
At 1st Optimal, we look at the full picture, including symptoms, health history, metabolic markers, sleep, nutrition, body composition, and treatment goals. The aim is not simply to make a lab value look different. It is to build a practical plan that helps you feel and function better while managing risk responsibly.
Book a free health consultation to discuss your symptoms and learn whether a personalized hormone health evaluation may be appropriate.
Educational only, not medical advice. Hormone therapy requires an individualized evaluation by a qualified healthcare professional.
